SCD1, which essentially adjusts the cellular ratio of SFAs to MUFAs, improves lipid metabolic profiles and insulin sensitivity24,85–89, maintains skin homeostasis90, and supports tumor growth91,92, metastasis93, cancer stemness94, and chemoresistance95. The gene discussed is SCD; the disease is neoplasm.